Примеры использования Metereddose inhalers на Английском языке и их переводы на Русский язык
{-}
-
Official
-
Colloquial
meet the remaining longterm needs of Parties still producing metereddose inhalers using CFCs.
In response to questions about the 2010 deadline for the transition to non-CFC metereddose inhalers and the resources needed for transition strategies,
Mindful that, according to decision IV/25, the use of chlorofluorocarbons for metereddose inhalers does not qualify as an essential use if technically
The exclusion of CFC consumption for metereddose inhalers from that plan had therefore restricted the time available to achieve the CFC phaseout required to meet the Protocol's 2007 deadline for an 85 per cent reduction in CFC consumption.
that would be sufficient for the manufacture of such CFCbased metereddose inhalers as would be required to complete the global transition to CFCfree inhalers. .
Economic Assessment Panel to report to the Open-ended Working Group at its twenty-seventh meeting on various aspects related to the possibility of a final batch of CFCs being produced exclusively for metereddose inhalers in both Parties operating under paragraph 1 of Article 5
Regarding the recommendation to authorize half of the amount nominated for use in metereddose inhalers, he requested the Panel to reconsider its decision in view of new information that had not been taken into account in the assessment:
metered-dose inhalers with alternative products but that at the present time still require a limited amount of pharmaceutical grade chlorofluorocarbons to produce metereddose inhalers, as demonstrated by current essential-use exemption requests granted by the Parties.
In considering the issue of phasing out CFCs in metereddose inhalers, the Committee may wish to note that Bangladesh is one of the eight Parties operating under paragraph 1 of Article 5 that submitted essential-use nominations for CFC metered-dose inhalers for 2010.
which included a review of the Article 5 Parties producing CFCbased metereddose inhalers which might face situations of non-compliance because of that continuing use.
recommended quantities for a limited campaign production of chlorofluorocarbons exclusively for metereddose inhalers in Article 5
the Meeting of the Parties had called on Parties to consider a possible decision that would address the situation of Article 5 Parties that were facing challenges in their efforts to phase out the use of CFCs in metereddose inhalers.
The representative of the Secretariat recalled that under decision XVIII/16 the Committee had been requested to consider all possible options when considering potential non-compliance by Article 5 Parties manufacturing CFCbased metereddose inhalers and to give special consideration to such Parties in the light of the information received from them,
Economic Assessment Panel on various aspects related to the possibility of a final batch of CFCs being produced exclusively for metereddose inhalers both in Parties operating under paragraph 1 of Article 5
some other developing countries which produced metered-dose inhalers would face in supplying effective and affordable metereddose inhalers to their populations once the Protocol's 85 per cent CFC reduction provision went into effect in 2007.
Specifically, Parties heard from the Panel on its recommended approval of 248 tonnes of CFCs for 2009 for metereddose inhalers in the Russian Federation
Responding to questions about Bangladesh's progress with phasing out CFCs for uses other than metereddose inhalers, the representative of UNIDO explained that the Executive Committee had already approved a national phase-out plan for CFCs used in refrigeration and air-conditioning,
Full details of the Panel's findings related to requests for exemptions for CFCs for metereddose inhalers can be found in chapter 1 of volume 1 of its 2010 progress report,
recommended quantities for a limited campaign production of CFCs exclusively for metereddose inhalers both in Parties operating under paragraph 1 of Article 5
recommended quantities for a limited campaign production of chlorofluorocarbons exclusively for metereddose inhalers in both Parties operating under paragraph 1 of Article 5